Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New moms may ease stitching pain with breastfeeding, VR, or a stress ball

NCT ID NCT07510477

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at three simple methods—breastfeeding, using a stress ball, or wearing virtual reality goggles—to help first-time mothers feel less pain and anxiety during episiotomy repair (stitching) after giving birth. About 120 women will be randomly assigned to one of these groups or standard care. Researchers will measure pain, anxiety, stress hormones, and comfort levels to see which approach works best.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pregnant women between 18 and 45 years of age. * Primiparous women (first-time mothers). * Gestational age between 37 and 42 weeks (term pregnancy). * Singleton pregnancy with a vertex presentation. * Spontaneous vaginal delivery requiring a mediolateral episiotomy. * Newborn birth weight between 2500 and 4500 grams. * Newborn Apgar scores of 7 or higher at the 1st and 5th minutes. * Ability to read, understand, and speak Turkish fluently. * Voluntary participation with signed informed consent. Exclusion and Withdrawal Criteria: * Requesting to withdraw from the research at any stage. * Presence of any congenital anomalies in the newborn. * Presence of maternal visual or hearing impairments. * Occurrence of fetal mortality or morbidity. * Occurrence of anal sphincter injury or 3rd/4th-degree lacerations in addition to the episiotomy. * Performance of the episiotomy repair in an operating room. * Use of assisted delivery methods (e.g., vacuum extraction). * Administration of sedative drugs or extra anesthetic agents (excluding routine local perineal infiltration). * Development of maternal complications (e.g., postpartum hemorrhage) preventing data collection.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Acute Pain anxiety anxiety disorder Breast Feeding Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Nazilli State Hospital

    Aydin, Nazilli, 09800, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.